Service agreement
Ended Awarded Last action
- Contract number
- 75N91019F90052
- Awardee
-
Life Technologies Corporation UEI EB8QTC6575E7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,319
Award facts
- Contract value 100% obligated
- $3,318.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1,106 | |
| Original award | $4,425 |
About this award
The National Cancer Institute awarded a BPA call to Life Technologies Corporation (doing business as Thermo Fisher Scientific) on May 28, 2019, valued at $3,318.78 under a firm fixed-price service agreement. This contract represents a de-obligation of funds from fiscal year 2019 expiring lines in accordance with National Institutes of Health Office of Administrative and Legal Management communication, with an ultimate completion date of July 29, 2024. The work is to be performed in Bethesda, Maryland, and no set-aside designation was used in this procurement. Life Technologies Corporation is a prominent manufacturer of scientific instruments, reagents, and consumables that provides specialized biotechnology products and services across multiple federal agencies, positioning it as a competitive vendor for this procurement action.
This contract award reflects the National Cancer Institute's engagement with Life Technologies Corporation through an existing Blanket Purchase Agreement vehicle, enabling streamlined procurement of scientific resources to support the agency's research mission. As a leading supplier of advanced laboratory equipment including genetic analyzers, real-time PCR systems, flow cytometers, and nucleic acid extraction equipment, Life Technologies has demonstrated consistent capability in supporting federal research initiatives. The relatively modest contract value reflects the de-obligation mechanism rather than the full scope of potential services available through the underlying BPA framework, which the company maintains across multiple federal agencies including the National Institutes of Health, Department of Defense, and Centers for Disease Control and Prevention.
Quick answers
Who was awarded contract 75N91019F90052?
75N91019F90052 was awarded to Life Technologies Corporation by National Cancer Institute (National Institutes of Health) on May 28, 2019.
How much is contract 75N91019F90052 worth?
The government has obligated $3,319 on 75N91019F90052.
Is contract 75N91019F90052 an order under another contract?
Yes. 75N91019F90052 is a BPA call under HHSN263201200063B, a blanket purchase agreement.
Was contract 75N91019F90052 competed?
The extent of competition for 75N91019F90052 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award